Laboratory of Virology and Chemotherapy, Department of Microbiology and Immunology, Rega Institute, KU Leuven, Belgium.
International Centre for Genetic Engineering and Biotechnology, Trieste.
J Infect Dis. 2018 Oct 20;218(11):1753-1758. doi: 10.1093/infdis/jiy398.
A safe and highly efficient antiviral is needed for the prophylaxis and/or treatment of viral diarrhea. We here demonstrate the in vitro antiviral activity of four 2'-C-methyl nucleoside analogues against noro-, rota-, and sapoviruses. The most potent nucleoside analogue, 7-deaza-2'-C-methyladenosine, inhibits replication of these viruses with a 50% effective concentration < 5 µM. Mechanistically, we demonstrate that the 2'-C-methyl nucleoside analogues act by inhibiting transcription of the rotavirus genome. This provides the first evidence that a single viral-diarrhea-targeted treatment can be developed through a viral-polymerase-targeting small molecule.
需要一种安全且高效的抗病毒药物来预防和/或治疗病毒性腹泻。我们在此展示了四种 2'-C-甲基核苷类似物对诺如病毒、轮状病毒和肠病毒的体外抗病毒活性。最有效的核苷类似物 7-脱氮-2'-C-甲基腺苷对这些病毒的复制具有 50%有效浓度 < 5 µM 的抑制作用。从机制上讲,我们证明 2'-C-甲基核苷类似物通过抑制轮状病毒基因组的转录起作用。这首次证明了通过靶向病毒聚合酶的小分子可以开发出针对单一病毒性腹泻的治疗方法。